Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy
Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy
Recruiting · NCT07256015 · Registry updated 2025-12-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, follicular lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, psoriasis, skin disorder | Recruiting | Not stated | 2025-12-01 | NCT07256015 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bristol-Myers Squibb | 422 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Azienda Ospedaliera Universitaria Integrata Di Verona | Verona | Italy | 2 |